"California Eye Specialists' leading team of eyecare experts work to provide patients with the highest quality care at the forefront of technology. We welcome you to learn more about our providers and their subspecialties."

During the past decade, California Eye Specialists Medical Group, Inc conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Eye Specialists Medical Group, Inc" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Aerie Pharmaceuticals" with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored and "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Eye Specialists Medical Group, Inc" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "CBCC Global Research" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "California Eye Specialists Medical Group, Inc" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (2 trials), "Macular Edema" (2 trials), "Neovascular Age-related Macular Degeneration" (2 trials) and "Branch Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "California Eye Specialists Medical Group, Inc" in a lesser frequency.

Most popular intervention types in "California Eye Specialists Medical Group, Inc" are "Drug" (14 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (5 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials) and "PDS Implant Pre-Filled with 100 mg/mL Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Eye Specialists Medical Group, Inc" are 16 trials for "All" genders.

Currently, there are NaN active trials in "California Eye Specialists Medical Group, Inc". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in California Eye Specialists Medical Group, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in California Eye Specialists Medical Group, Inc, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".